These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29650840)

  • 1. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
    Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
    Matsusaki K
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.
    Hisakane K; Ohmatsu H; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Goto K
    J Nippon Med Sch; 2017; 84(5):231-236. PubMed ID: 29142184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
    Okumura K; Tani S; Shiogai Y; Kodama M; Mekata E; Tan T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):667-70. PubMed ID: 22504699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.
    ; Matsusaki K; Ohta K; Yoshizawa A; Gyoda Y
    Int J Clin Oncol; 2011 Aug; 16(4):395-400. PubMed ID: 21347629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
    Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel in Advanced Gastric Cancer].
    Kawada J; Nishino M; Hosoda Y; Hoshino H; Okano M; Nagai K; Okuyama M; Kim Y; Tsujinaka T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1951-1953. PubMed ID: 28133186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis.
    Togami S; Hori S; Kamio M; Matsuo T; Yoshinaga M; Douchi T
    Eur J Gynaecol Oncol; 2014; 35(3):301-3. PubMed ID: 24984546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced gastric cancer with carcinomatosa peritonitis effectively treated by 5-FU and low-dose CDDP therapy].
    Saito E; Kunii Y; Wada G; Tsuchiya S; Yamasaki T; Sakakibara N
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1153-6. PubMed ID: 9239170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Unresectable Pancreatic Cancer with Massive Cancerous Ascites Responsive to KM-CART].
    Shirakawa K; Hirahara S; Kubota H; Kuhara Y; Toyota K; Yano R; Kobayashi H; Hashimoto Y; Yokoyama Y; Sakashita Y; Miyamoto K
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):81-83. PubMed ID: 33468729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two Cases of Peritoneal Dissemination of Gastric Cancer Treated with CART Followed by Chemotherapy].
    Kitagawa Y; Katsuno A; Tamura N; Harada T; Abe S; Hamasaki S; Machida T; Nakanishi A; Ami K; Umetani N
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1887-1889. PubMed ID: 33468862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake.
    Iwasa S; Goto M; Yasui H; Nishina T; Takahari D; Nakayama N; Taira K; Kusaba H; Fuse N; Hironaka S; Shimada Y; Nakajima TE
    Jpn J Clin Oncol; 2012 Sep; 42(9):787-93. PubMed ID: 22782960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of unresectable gastric cancer in a patient who maintained a good quality of life with multidisciplinary treatment].
    Kato R; Okada K; Ebisui C; Wada Y; Makino S; Takeoka T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2280-2. PubMed ID: 24394085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
    Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
    Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
    Yasuda K; Asou M; Asakawa T; Araki M
    J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
    Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
    Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
    Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
    Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Effective Peritoneo-Venous Shunt for Refractory Malignant Ascites in a Gastric Cancer Patient with Peritoneal Dissemination].
    Sugamoto Y; Arasawa T; Fukunaga T; Tasaki K; Kuboshima M; Muto Y; Sazuka T; Kimura M; Asai Y; Fujita E; Ota T; Matsubara H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2059-2061. PubMed ID: 33468800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.